Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Antineoplastic anthracycline antibiotic disclosed by Mercian

Dec. 19, 1996

Mercian reports new antitumor anthracycline

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

New lipophilic drug delivery agents from Scotia

Dec. 19, 1996

Bayer describes new ASA derivatives

Dec. 19, 1996

Therapeutically active nicotinic acid esters described by Scotia

Dec. 19, 1996

Carbapenem esters revealed by SKB

Dec. 18, 1996

Mercian discloses novel antitumor anthracycline antibiotics

Dec. 18, 1996

Sandoz reports on tetraline derivatives for neurological disorders

Dec. 18, 1996

Dainippon describes agents that act selectively on peripheral benzodiazepine receptors

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...